Searching Synergistic Drug Combinations to Treat Cancer

来源 :2016第九届世界癌症大会 | 被引量 : 0次 | 上传用户:TNT2000
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Synergistic drug combinations have long been highly desired in treating complex disease of cancer.Yet,prioritizing synergistic agents from the large pool of potential combinatorial drugs is highly challenging.
其他文献
Nanotechnology is a kind of novel technologies that provides a flexible platform for the development of effective therapeutic nanomaterials.These nanometerials can provoke a desired response in a biol
会议
Daiichi Sankyo is a pharmaceutical company which develops innovative drugs for patients in serious diseases.Oncology is one of the focused therapeutic areas and currently 21 projects are under clinica
会议
The preparation and cellular action of drug-delivery systems (DDS) are normally based on threedifferent processes.First the loading of the system with the therapeutic molecule that needs a coherent de
会议
The human cancerous inhibitor ofPP2A (CIP2A) is regarded as a novel target for cancer therapy as its overexpression in 65% to 90% of tissues in almost all studied human cancers correlates with cancer
会议
The glucocorticoids are very effective inhibitors of the induction of several cancers and used to treat certain early stage cancers.The major concerns with using glucocorticoids for the treatment of c
会议
Cancer cells are more susceptible to H2O2 induced cell death than normal cells.H2O2-activatable Nano-Mn(Ⅱ) complexes could be used as both MRI image and cancer response therapy agents in hypoxic envir
会议
Background: Chemotherapy is still the effective strategy for treating cancer.It is important to explore anticancer agents from Traditional Chinese Medicine and Natural products.
会议
The inhibition of enzymes responsible for the formation of active estrogens in tumors is now considering as the one of most promising approaches for the treatment of hormone-dependent tumor diseases,s
会议
The incidence of CHD complications is much lower in premenopausal women then in man or postmenopausal women of similar age.After menopause the gender difference is lost and the incidence of CHD compli
会议
Recent studies have suggested that mechanisms linked to the decreased intracellular drug accumulation such as reduced extracellular pH,increased intracellular pH,or linked to the altered intracellular
会议